MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.
Revenue projections:
Revenue projections for MEDPLUS MEDPLUS's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.
Financial Ratios:
currentRatio
2.90300
forwardPE
39.13855
debtToEquity
64.68900
earningsGrowth
0.43000
revenueGrowth
0.06500
grossMargins
0.25567
operatingMargins
0.04781
trailingEps
16.28000
forwardEps
19.81167
MEDPLUS's current ratio is 2.903, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting MEDPLUS has no trouble covering its short-term financial obligations. MedPlus Health Services Limited's forward EPS being higher than its trailing EPS indicates that the company is expected to achieve greater profitability this financial year. This suggests improving earnings and a stronger financial position compared to the previous year's performance.
Price projections:
Price projections for MEDPLUS The current valuation of MEDPLUS against its projections does not reveal significant risks or opportunities. This neutral assessment implies a stable market, where investors may prefer to maintain their positions until future trends become clearer.
Recommendation changes over time:
Recommendations trend for MEDPLUS
A recent buy bias from analysts toward MedPlus Health Services Limited indicates strong confidence in the stock's future performance. This could encourage investors to park their money in MedPlus Health Services Limited, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An investor-focused analysis of how 2025 tariffs are reaching consumers in 2026,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.